SERPINE1 and pleural mesothelioma: The present study aims to validate these five IHC markers, previously selected via gene-expression analysis (Plasminogen Activator Inhibitor 1—PAI1—encoded by the SERPINE1 gene, CFB, Mesothelin, Claudin-15, and PAK4), to improve the diagnosis and subtyping of pleural mesothelioma.